Park National Corp OH raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 2.1% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,247 shares of the healthcare conglomerate's stock after purchasing an additional 46 shares during the period. Park National Corp OH's holdings in UnitedHealth Group were worth $1,154,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in the company. Advocacy Wealth Management Services LLC increased its holdings in shares of UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate's stock worth $30,000 after buying an additional 25 shares during the period. Cascade Investment Advisors Inc. boosted its position in shares of UnitedHealth Group by 100.0% in the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate's stock worth $31,000 after purchasing an additional 30 shares in the last quarter. Evolution Advisers Inc. bought a new stake in shares of UnitedHealth Group in the 1st quarter worth approximately $38,000. Rise Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $38,000. Finally, Cordant Inc. bought a new stake in shares of UnitedHealth Group in the 1st quarter worth approximately $45,000. Hedge funds and other institutional investors own 87.25% of the company's stock.
Get
UnitedHealth Group alerts:
Analyst Ratings Changes
A number of equities research analysts have weighed in on the stock. Credit Suisse Group boosted their target price on shares of UnitedHealth Group from $575.00 to $579.00 and gave the company an "outperform" rating in a research note on Monday, July 18th. UBS Group boosted their target price on shares of UnitedHealth Group from $545.00 to $570.00 and gave the company a "neutral" rating in a research note on Thursday, July 21st. Loop Capital began coverage on shares of UnitedHealth Group in a research note on Thursday, June 16th. They set a "buy" rating and a $575.00 target price for the company. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $556.00 to $569.00 and gave the company a "buy" rating in a research report on Thursday, September 8th. Finally, Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $613.00 to $612.00 and set an "overweight" rating for the company in a research report on Wednesday, May 25th. Three analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $585.65.
Insider Activity
In related news, EVP Erin Mcsweeney sold 1,273 shares of the stock in a transaction dated Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total value of $635,227.00. Following the sale, the executive vice president now directly owns 8,104 shares of the company's stock, valued at approximately $4,043,896. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Andrew Witty sold 11,376 shares of the stock in a transaction dated Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the sale, the chief executive officer now directly owns 76,559 shares of the company's stock, valued at approximately $40,415,496.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,273 shares of the stock in a transaction dated Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total transaction of $635,227.00. Following the completion of the sale, the executive vice president now directly owns 8,104 shares in the company, valued at $4,043,896. The disclosure for this sale can be found here. In the last three months, insiders have sold 140,324 shares of company stock worth $75,086,185. 0.40% of the stock is currently owned by corporate insiders.
UnitedHealth Group Stock Down 0.4 %
UNH opened at $521.02 on Friday. The firm has a 50-day simple moving average of $529.24 and a two-hundred day simple moving average of $511.32. UnitedHealth Group Incorporated has a 52 week low of $383.12 and a 52 week high of $553.29. The company has a market capitalization of $487.35 billion, a PE ratio of 27.21, a price-to-earnings-growth ratio of 1.64 and a beta of 0.76. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60.
UnitedHealth Group (NYSE:UNH – Get Rating) last released its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating the consensus estimate of $5.24 by $0.33. The business had revenue of $80.33 billion during the quarter, compared to the consensus estimate of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business's revenue was up 12.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $4.70 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th will be given a dividend of $1.65 per share. This represents a $6.60 annualized dividend and a dividend yield of 1.27%. The ex-dividend date of this dividend is Friday, September 9th. UnitedHealth Group's dividend payout ratio is 34.46%.
About UnitedHealth Group
(Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Featured Articles
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It's a Down Week
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
